The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.  The Fool has written over 600 articles on AstraZeneca.
3 Horrible Stocks for Retirees

In today's low-interest-rate environment, it is natural for retirees to be attracted to stocks th...

3 Big Battles Brewing in Biotech

SOURCE: FLICKR USER STOCKMONKEYS.COM. Competitors are always angling to dethrone established lead...



Stock Performance

View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $25.89
Prev Close: $25.81
Open: $25.94
Bid: $25.90
Ask: $26.23
Day's Range: $25.86 - $26.11
52wk Range: $25.76 - $35.04
Volume: 8,836,505
Avg Vol 7,787,038
Market Cap: $65B
P/E (ttm): 11.57
EPS (ttm): $2.23
Div & Yield: $0.90 (5.3%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
700 Outperform
43 Underperform
CAPS All Stars
 
157 Outperform
8 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

83% Approve

Based on 336 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers